Argyle Capital Partners, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2079995 LOS ANGELES, CA

Position in BMY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$381,905

-$11,228 QoQ

Shares Held

6,628

+2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#1,700

of 2,506 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 98% Shared 2% None 0%

Healthcare · as of Jun 30, 2026

Argyle Capital Partners, LLC holds $5,444,856 across 5 Drug Manufacturers - General names. BMY ranks #4 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	9,306	$2,341,761
2	AMGN	Amgen Inc	4,851	$1,756,643
3	NVS	Novartis AG	4,094	$641,611
4	BMY	Bristol Myers Squibb Co This page	6,628	$381,905
5	PFE	Pfizer Inc	13,411	$322,936

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$381,905	6,628	+2.3%	Shares	Sole	2026-08-07
2026-03-31	$393,133	6,482	-33.9%	Shares	Sole	2026-05-07
2025-12-31	$528,558	9,799	-4.6%	Shares	Sole	2026-02-17
2025-09-30	$463,266	10,272	+7.2%	Shares	Sole	2025-11-14
2025-06-30	$443,689	9,585	-28.2%	Shares	Sole	2025-08-13
2025-03-31	$814,155	13,349	-5.9%	Shares	Sole	2025-08-13
2024-12-31	$802,303	14,185	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.